Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · IEX Real-Time Price · USD
2.070
-0.180 (-8.00%)
At close: Jul 2, 2024, 4:00 PM
2.140
+0.070 (3.38%)
After-hours: Jul 2, 2024, 7:22 PM EDT
Omega Therapeutics Market Cap
Omega Therapeutics has a market cap or net worth of $114.17 million as of July 2, 2024. Its market cap has decreased by -70.45% in one year.
Market Cap
114.17M
Enterprise Value
181.41M
1-Year Change
-70.45%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since the IPO on July 30, 2021, Omega Therapeutics's market cap has decreased from $792.62M to $114.17M, a decrease of -85.60%. That is a compound annual growth rate of -48.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 124.10M | -25.24% |
| Dec 29, 2023 | 166.00M | -39.50% |
| Dec 30, 2022 | 274.40M | -49.31% |
| Dec 31, 2021 | 541.30M | -31.71% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 127.85M |
| Telomir Pharmaceuticals | 125.84M |
| I-Mab | 124.78M |
| Kodiak Sciences | 124.51M |
| Regulus Therapeutics | 124.39M |
| Electromed | 122.48M |
| Tevogen Bio Holdings | 122.33M |
| Harvard Bioscience | 120.73M |